Correlation Between Monopar Therapeutics and Science

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Science at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Science into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Science Applications International, you can compare the effects of market volatilities on Monopar Therapeutics and Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Science.

Diversification Opportunities for Monopar Therapeutics and Science

MonoparScienceDiversified AwayMonoparScienceDiversified Away100%
-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between Monopar and Science is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Science Applications Internati in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Science Applications and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Science Applications has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Science go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and Science

Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 36.94 times more return on investment than Science. However, Monopar Therapeutics is 36.94 times more volatile than Science Applications International. It trades about 0.02 of its potential returns per unit of risk. Science Applications International is currently generating about -0.02 per unit of risk. If you would invest  4,146  in Monopar Therapeutics on November 25, 2024 and sell it today you would lose (121.00) from holding Monopar Therapeutics or give up 2.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy85.71%
ValuesDaily Returns

Monopar Therapeutics  vs.  Science Applications Internati

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb 050100150
JavaScript chart by amCharts 3.21.15MNPR 808625AA5
       Timeline  
Monopar Therapeutics 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb2025303540455055
Science Applications 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Science Applications International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Science is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
JavaScript chart by amCharts 3.21.15NovDecJanFebDecJanFeb95.59696.59797.598

Monopar Therapeutics and Science Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-23.58-17.66-11.74-5.82-0.026.212.7219.2425.7732.29 0.51.01.52.02.53.03.5
JavaScript chart by amCharts 3.21.15MNPR 808625AA5
       Returns  

Pair Trading with Monopar Therapeutics and Science

The main advantage of trading using opposite Monopar Therapeutics and Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Science will offset losses from the drop in Science's long position.
The idea behind Monopar Therapeutics and Science Applications International pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data